Effect of delaying prophylaxis against CMV in D+/R- solid organ transplant recipients in the development of CMV-specific cellular immunity and occurrence of late CMV disease. [electronic resource]
Producer: 20160816Description: 561-70 p. digitalISSN:- 1532-2742
- Antiviral Agents -- therapeutic use
- Cytomegalovirus -- drug effects
- Cytomegalovirus Infections -- drug therapy
- Female
- Ganciclovir -- therapeutic use
- Humans
- Immunity, Cellular
- Incidence
- Liver Transplantation
- Male
- Middle Aged
- Postoperative Complications -- prevention & control
- Proportional Hazards Models
- Prospective Studies
- Risk Factors
- Spain -- epidemiology
- Survival Analysis
- Transplant Recipients
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Observational Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.